Seeking Alpha

Mike Havrilla » Comments » ACHN

  • Looking for Laggards After the Latest Market Rally [View article]
    Here is the rest of the article from my blog with a valuation comparison of HITK vs. CPD:

    With shares of HITK trading up today by about 25% on record quarterly revenue of $25.1M and diluted net income of $1.1M or 9 cents per share, Caraco appears extremely undervalued at current levels of $3.50 per share. Caraco trades at the lowest price to sales ratio [PSR] in the generic drug industry at just 0.24X with a trailing price to earnings ratio [PE] of less than 4X, zero debt, $33.6M cash, and a market cap of $123M. As a comparison HITK trades at a PSR of 0.84X with an estimated forward PE of 16X, negligible debt, $16.1M cash, and a market cap of $71M.
    Dec 09 18:11 pm |Rating: 0 0 |Link to Comment
More on ACHN by Mike Havrilla
Comments by Ticker
AAWW, ABIO, ABMD, ABT, ABX, ACAD, ACCP.OB, ACHN, ACLI, ACOR, ACTC.PK, ACUR, ACUS, ADLR, ADLS, ADLS.OB, AEZS, AFFX, AGEN, AGF, AGN, AHBIF.PK, AIQ, AIS, ALEX, ALGT, ALKS, ALO, ALPMF.PK, ALTH, ALV, ALVR, AMAG, AMGN, AMR, AMX, ANDS, ANPI, APPA, APPX, ARDM.OB, ARIA, ARKTF.PK, ARNA, ARQL, ARYX, ASO, ASTM, ATHX, ATSI,
Mike Havrilla's
Comments Stats
172 comments
Rating: 27 (48 - 21 )